Therapeutic Drug Monitoring in the Elderly

farmakoloji-11-2-2023-wos

Zeynep Güneş ÖZÜNALa

aAtlas University Faculty of Medicine, Department of Medical Pharmacology, İstanbul, Türkiye

ABSTRACT
Therapeutic drug monitoring (TDM) is a strategy to guide a dosing regimen by measuring drug concentration. The decision of a TDM order, the preanalytical phase, analysis, interpretation, and adjustment of pharmacotherapy are sequential processes in TDM. Amikacin, amisulpride, carbamazepine, citalopram, clomipramine, cyclosporin, desipramine, digoxin, everolimus, fluphenazine, gentamycin, haloperidol, imipramine, lithium, methotrexate, nortriptyline, olanzapine, phenobarbital, phenytoin, tacrolimus, valproic acid, and vancomycin are among the recommended medications for TDM. Despite some limitations, TDM can contribute to safe and effective pharmacotherapy for the elderly and has promising future prospects.
Keywords: Drug monitoring; the elderly; precision medicine; digoxin; aminoglycosides; tacrolimus

Referanslar

  1. Ruiz JG, Array S, Lowenthal DT. Therapeutic Drug Monitoring in the Elderly. Am J Ther. 1996;3(12):839-60. [Crossref]  [PubMed]
  2. Gross AS. Best practice in therapeutic drug monitoring. Br J Clin Pharmacol. 1998;46(2):95-9. [Crossref]  [PubMed]  [PMC]
  3. The selection and use of essential in vitro diagnostics: report of the second meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2019 (including the second WHO model list of essential in vitro diagnostics). Geneva: World Health Organization; 2019 (WHO Technical Report Series, No. 1022). Licence: CC BY-NC-SA 3.0 IGO.
  4. Charfi R, Ben Sassi M, Gaies E, Jebabli N, Daghfous R, Trabelsi S. Digoxin therapeutic drug monitoring: age influence and adverse events. Tunis Med. 2020;98(1):35-40.
  5. Yilmaz İ, Bilgili S, Bozkaya G. Evaluation of digoxin levels in elderly patients in a training hospital: An 11-year follow-up. Turk Geriatri Derg. 2020;23(1):108-17. [Crossref]
  6. Fraisse T, Gras Aygon C, Paccalin M, Vitrat V, De Wazieres B, Baudoux V, et al. Aminoglycosides use in patients over 75 years old. Age Ageing. 2014;43(5):676-81. [Crossref]  [PubMed]
  7. Leon-Djian CB, Bourguignon L, Späth HM, Maire P. Étude coût-efficacité de l'adaptation bayésienne des posologies des aminosides en gériatrie [Cost-effectiveness analysis of active TDM in elderly patients treated with aminoglycosides]. Therapie. 2011;66(5):445-52. French. [Crossref]  [PubMed]
  8. Ohieku JD, Ummatte I, Mubi BM, Anjori CO, Okoro RN, Ikunaiye NY, et al. Identification of geriatric patients who will potentially benefit from medical care, therapeutic drug monitoring and pharmaceutical care interventions in renal, endocrine and cardiovascular diseases. World J Pharm Pharm Sci. 2021;10(12):1773-86.
  9. Puisset F, Mseddi M, Mourey L, Pouessel D, Blanchet B, Chatelut E, et al. Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer. Cancers (Basel). 2023;15(1):313. [Crossref]  [PubMed]  [PMC]
  10. Cattaneo D, Falcone M, Gervasoni C, Marriott DJE. Therapeutic Drug Monitoring of Antibiotics in the Elderly: A Narrative Review. Ther Drug Monit. 2022;44(1):75-85. [Crossref]  [PubMed]
  11. McLachlan AJ. Therapeutic Drug Monitoring in Older People. Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. Elsevier Inc.; 2016. p.213-29. [Crossref]  [PubMed]  [PMC]
  12. Suchánková H, Lečbychová K, Strojil J, Fürst T. Individualized dosing of vancomycin in geriatric patients. Epidemiol Mikrobiol Imunol. 2020;69(4):172-180. English.
  13. Meng L, Wong T, Huang S, Mui E, Nguyen V, Espinosa G, et al. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center. Pharmacotherapy. 2019;39(4):433-42. [Crossref]  [PubMed]
  14. Voulgaridou G, Paraskeva T, Ragia G, Atzemian N, Portokallidou K, Kolios G, et al. Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years. Pharmaceutics. 2023;15(9):2181. [Crossref]  [PubMed]  [PMC]
  15. Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017. Vol. 51, Pharmacopsychiatry. Georg Thieme Verlag; 2018. p.9-62. [Crossref]  [PubMed]
  16. Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in elderly patients. Drugs Aging. 2000;16(3):165-77. [Crossref]  [PubMed]
  17. Wright DF, Begg EJ. The 'apparent clearance' of free phenytoin in elderly vs. younger adults. Br J Clin Pharmacol. 2010;70(1):132-8. [Crossref]  [PubMed]  [PMC]
  18. Mann NK, Mathes T, Sönnichsen A, Pieper D, Klager E, Moussa M, et al. Potentially Inadequate Medications in the Elderly: PRISCUS 2.0-First Update of the PRISCUS List. Dtsch Arztebl Int. 2023;120(Forthcoming):3-10. [Crossref]  [PubMed]  [PMC]
  19. Aonuma K, Shiga T, Atarashi H, Doki K, Echizen H, Hagiwara N, et al.; Japanese Circulation Society and the Japanese Society of Therapeutic Drug Monitoring Joint Working Group. Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs Clinical Use of Blood Drug Concentration Monitoring (JCS 2015)　- Digest Version. Circ J. 2017;81(4):581-612. [Crossref]  [PubMed]
  20. Roberts DM, Gallapatthy G, Dunuwille A, Chan BS. Pharmacological treatment of cardiac glycoside poisoning. Br J Clin Pharmacol. 2016;81(3):488-95. [Crossref]  [PubMed]  [PMC]
  21. Bressán IG, Giménez MI, Llesuy SF. Validation of a simple liquid chromatography coupled to tandem mass spectrometry method for the simultaneous determination of tacrolimus, sirolimus, everolimus and cyclosporin A in dried matrix on paper discs. J Mass Spectrom Adv Clin Lab. 2021;19:7-19. [Crossref]  [PubMed]  [PMC]
  22. Udomkarnjananun S, Francke MI, De Winter BCM, Mulder MB, Baan CC, Metselaar HJ, den Hoed CM, Hesselink DA. Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology. Best Pract Res Clin Gastroenterol. 2021;54-55:101756. [Crossref]  [PubMed]
  23. Ozunal ZG, Ongen İpek B. Therapeutic Drug Monitoring Characteristics in a Tertiary University Hospital in 2019. Cureus. 2020;12(4):e7612. [Crossref]
  24. Scuderi C, Parker S, Jacks M, John GT, McWhinney B, Ungerer J, et al. Fingerprick Microsampling Methods Can Replace Venepuncture for Simultaneous Therapeutic Drug Monitoring of Tacrolimus, Mycophenolic Acid, and Prednisolone Concentrations in Adult Kidney Transplant Patients. Ther Drug Monit. 2023;45(1):69-78. [Crossref]  [PubMed]
  25. Garzón V, Pinacho DG, Bustos RH, Garzón G, Bustamante S. Optical Biosensors for Therapeutic Drug Monitoring. Biosensors (Basel). 2019;9(4):132. [Crossref]  [PubMed]  [PMC]
  26. Ates HC, Roberts JA, Lipman J, Cass AEG, Urban GA, Dincer C. On-Site Therapeutic Drug Monitoring. Vol. 38, Trends in Biotechnology. Elsevier Ltd.; 2020. p.1262-77. [Crossref]  [PubMed]